Biomarker
HbA1c (Glycated Haemoglobin)
Last updated Sun May 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
What it is
Glucose covalently attaches to haemoglobin in red blood cells; the percentage of glycated haemoglobin (HbA1c) reflects the average plasma glucose over the prior ~3 months (the red-cell lifespan).
Reference ranges
- Normal: <5.7% (<39 mmol/mol)
- Pre-diabetes: 5.7–6.4% (39–47 mmol/mol)
- Diabetes: ≥6.5% (≥48 mmol/mol)
For longevity-oriented targets, many practitioners aim for <5.5% in metabolically healthy adults, with the caveat that haemoglobinopathies and red-cell-lifespan variations distort the test.
Why it matters for longevity
- Strongly predicts cardiovascular events independent of overt diabetes.
- Higher HbA1c in midlife tracks dementia risk in long-term cohorts.
- Glycation of structural proteins (collagen, lens crystallins, neuronal proteins) accumulates with sustained hyperglycaemia — an “aging from glucose” mechanism.
What lowers HbA1c
- Weight loss.
- Carbohydrate quality (less refined; more fibre).
- Exercise, particularly resistance + aerobic.
- Metformin, SGLT2 inhibitors, GLP-1 agonists.
- Acarbose targets post-prandial spike.
Related entries
Type 2 diabetes, Fasting insulin / HOMA-IR, Mediterranean diet.
References
- Selvin, E. et al. Glycated hemoglobin, diabetes, and cardiovascular risk. N. Engl. J. Med. 362, 800–811 (2010).